To determine the effect of SMRT deletion on lipogenic and gluconeogenic-related gene expression prior to the onset of obesity, we analyzed various tissues in the 3rd male cohort (4 weeks post-tamoxifen) and female cohort (6 weeks post-tamoxifen). The gene discussed is NCOR2; the disease is Obesity.